Qube Research & Technologies (QRT)
FDMT icon

Qube Research & Technologies (QRT)’s 4D Molecular Therapeutics FDMT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-106,530
Closed -$593K – 3600
2024
Q4 		$593K Sell
106,530
-54,766
-34% -$430K ﹤0.01% 2390
2024
Q3 		$1.74M Buy
161,296
+74,840
+87% +$1.24M ﹤0.01% 1808
2024
Q2 		$1.81M Buy
86,456
+62,065
+254% +$1.56M ﹤0.01% 1680
2024
Q1 		$777K Buy
24,391
+2,538
+12% +$64.8K ﹤0.01% 2290
2023
Q4 		$443K Buy
+21,853
New +$288K ﹤0.01% 2362
2021
Q1 		– Sell
-16,496
Closed -$684K – 2058
2020
Q4 		$684K Buy
+16,496
New +$681K 0.01% 1000

Other funds holding FDMT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FDMT Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of 4D Molecular Therapeutics (FDMT) in Q1 2025, closing a stake of 106,530 shares — an estimated $593K sold.

Qube Research & Technologies (QRT) first reported a position in FDMT in Q4 2020 and held it in 6 quarters. The position peaked at $1.81M in Q2 2024. 125 funds tracked by Wall St. Rank hold FDMT as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining 4D Molecular Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 106,530 4D Molecular Therapeutics shares in Q1 2025, an estimated $593K.
  • Qube Research & Technologies (QRT) first reported a position in 4D Molecular Therapeutics in Q4 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s 4D Molecular Therapeutics position peaked at $1.81M in Q2 2024.
  • 125 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.